What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
The scientist’s investigation covers issues in Internal medicine, Acquired immunodeficiency syndrome, Immunology, Viral load and Pharmacology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Epidemiology, Viral disease, Prospective cohort study, Pediatrics and Risk factor.
His Immunology study combines topics in areas such as Odds ratio, Cohort study, Pneumonia, Proportional hazards model and Disease.
The concepts of his Viral load study are interwoven with issues in Drug resistance and Maraviroc.
His Pharmacology research includes themes of Elvitegravir, Clinical trial, Integrase inhibitor, Ritonavir and Raltegravir.
His most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection (1943 citations)
- CD4+ count-guided interruption of antiretroviral treatment. (1814 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Acquired immunodeficiency syndrome, Immunology, Virology and Gastroenterology.
His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Viral load.
His work carried out in the field of Viral load brings together such families of science as Efavirenz and Pharmacology.
His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Viral disease, Incidence, Epidemiology and Pediatrics.
His research related to Immunopathology and Antibody might be considered part of Immunology.
His research in Virology tackles topics such as Protease inhibitor which are related to areas like Ritonavir.
He most often published in these fields:
- Internal medicine (40.00%)
- Acquired immunodeficiency syndrome (24.63%)
- Immunology (23.58%)
What were the highlights of his more recent work (between 2007-2020)?
- Internal medicine (40.00%)
- Pharmacology (9.68%)
- Viral load (10.32%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Pharmacology, Viral load, Virology and Immunology.
The Internal medicine study combines topics in areas such as Gastroenterology and Efavirenz.
The various areas that he examines in his Pharmacology study include Protease inhibitor, Etravirine, Darunavir, Confidence interval and Ritonavir.
His study focuses on the intersection of Virology and fields such as Human papillomavirus with connections in the field of HPV infection.
His work deals with themes such as Transmission, Viral suppression, Logistic regression and Acquired immunodeficiency syndrome, which intersect with Immunology.
His Acquired immunodeficiency syndrome research includes elements of Tuberculosis, Pharmacotherapy, Public health, Pediatrics and Cohort.
Between 2007 and 2020, his most popular works were:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection (625 citations)
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection (494 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Nathan Clumeck mainly focuses on Internal medicine, Pharmacology, Immunology, Viral load and Efavirenz.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Emtricitabine.
His Gastroenterology research incorporates elements of Adverse effect and Hepatitis C virus.
The concepts of his Immunology study are interwoven with issues in Acquired immunodeficiency syndrome, Anal cancer, Disease, Public health and Prospective cohort study.
The subject of his Viral load research is within the realm of Virology.
His Efavirenz study also includes
- Lamivudine which is related to area like Zidovudine,
- Drug resistance which intersects with area such as Nevirapine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
